跳至主要内容
临床试验/JPRN-UMIN000025831
JPRN-UMIN000025831已完成2 期

High-dose clarithromycin monotherapy for Helicobacter pylori-negative or -eradicated gastrointestinal MALT lymphomas - High-dose CAM monotherapy for MALT lymphomas

Iwate Medical University School of Medicine, Division of Gastroenterology, Department of Internal Medicine0 个研究点目标入组 13 人开始时间: 2017年1月25日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Past history of allergy for CAM. 2) Taking drugs contraindicated for concomitant use with CAM, including calcium-channel blockers. 3) Prolonged QTc, sinus bradycardia (HR <50 bpm), or severe atrioventricular block detected by ECG. 4) Past history of gastrectomy. 5) Combined malignancies other than MALT lymphoma. 6) Severe renal dysfunction (eGFR<30 mL/min/1.73m2). 7) Liver dysfunction 8) Pregnant or possible pregnant women. 9) Others

研究者

发起方
Iwate Medical University School of Medicine, Division of Gastroenterology, Department of Internal Medicine

相似试验